Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Show other versions (1)

Bibliographic Details
Main Authors:	Magdalena Malm, Nina Kronqvist, Hanna Lindberg, Lindvi Gudmundsdotter, Tarek Bass, Fredrik Y. Frejd, Ingmarie Höidén-Guthenberg, Zohreh Varasteh, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, John Löfblom
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847116/?tool=EBI

Similar Items

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01)

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
by: Malm, Magdalena, et al.
Published: (2013)

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01)

Cellular effects of HER3-specific affibody molecules.
by: Lovisa Göstring, et al.
Published: (2012-01-01)

Affibody Molecules as Targeting Vectors for PET Imaging
by: Vladimir Tolmachev, et al.
Published: (2020-03-01)

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
by: Allal Boutajangout, et al.
Published: (2019-03-01)

Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
by: Sara S. Rinne, et al.
Published: (2020-02-01)

Affibody molecules targeting HER3 for cancer therapy
by: Bass, Tarek
Published: (2017)

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
by: Sara S. Rinne, et al.
Published: (2020-03-01)

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
by: Mohamed Altai, et al.
Published: (2018-10-01)

An Affibody Molecule Is Actively Transported into the Cerebrospinal Fluid via Binding to the Transferrin Receptor
by: Sebastian W. Meister, et al.
Published: (2020-04-01)

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
by: Javad Garousi, et al.
Published: (2017-07-01)

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers
by: Charles Dahlsson Leitao, et al.
Published: (2019-03-01)

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
by: Charles Dahlsson Leitao, et al.
Published: (2020-06-01)

Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
by: Maryam Oroujeni, et al.
Published: (2018-09-01)

Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
by: Jonas Persson, et al.
Published: (2021-09-01)

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
by: Ali Alhuseinalkhudhur, et al.
Published: (2020-03-01)

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
by: Haozhong Ding, et al.
Published: (2021-03-01)

Engineering of Affibody molecules targeting the Alzheimer’s-related amyloid β peptide
by: Lindberg, Hanna
Published: (2015)

Affibody-Binding Ligands
by: Annalisa Barozzi, et al.
Published: (2020-05-01)

Preclinical Evaluation of <sup>99m</sup>Tc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
by: Maryam Oroujeni, et al.
Published: (2021-03-01)

Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody–DM1 Drug Conjugates
by: Haozhong Ding, et al.
Published: (2019-08-01)

The Use of a Non-Conventional Long-Lived Gallium Radioisotope <sup>66</sup>Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule
by: Maryam Oroujeni, et al.
Published: (2021-02-01)

Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody<sup>®</sup> Molecules <sup>177</sup>Lu-ABY-271 and <sup>177</sup>Lu-ABY-027: Impact of DOTA Position on ABD Domain
by: Yongsheng Liu, et al.
Published: (2021-06-01)

Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.
by: Joanna Strand, et al.
Published: (2013-01-01)

Affibody ligands in immunotechnology applications
by: Rönnmark, Jenny
Published: (2002)

Affibody Molecules for PET Imaging
by: Strand, Joanna
Published: (2015)

PNA-mediated Affibody pretargeting
by: Tano, Hanna
Published: (2017)

Picomolar dichotomous activity of gnidimacrin against HIV-1.
by: Li Huang, et al.
Published: (2011-01-01)

Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA
by: Vladimir Tolmachev, et al.
Published: (2017-01-01)

Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
by: Tianqi Xu, et al.
Published: (2021-12-01)

Comparative Evaluation of Novel <sup>177</sup>Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
by: Hanna Tano, et al.
Published: (2021-01-01)

Versatile action of picomolar gradients of progesterone on different sperm subpopulations.
by: Diego Rafael Uñates, et al.
Published: (2014-01-01)

Affibody molecules for proteomic and therapeutic applications
by: Grönwall, Caroline
Published: (2008)

Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of Ga-Compared to In-Labeled Conjugates
by: Hadis Honarvar, et al.
Published: (2014-12-01)

Cystic fibrosis drug ivacaftor stimulates CFTR channels at picomolar concentrations
by: László Csanády, et al.
Published: (2019-06-01)

Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid
by: Windsor, Ian William, et al.
Published: (2020)

Process development for the control of solubility of Affibody® molecules
by: Dolfe, Lisa
Published: (2011)

Nondestructive in-line sub-picomolar detection of magnetic nanoparticles in flowing complex fluids
by: Lykourgos Bougas, et al.
Published: (2018-02-01)

Quantification of Neuropeptide Y with Picomolar Sensitivity Enabled by Guided-Mode Resonance Biosensors
by: Mohammad G. Abdallah, et al.
Published: (2019-12-01)